JPMORGAN CHASE & CO - 31 Dec 2024 SCHEDULE 13G Report for Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares (RADX)

Filing Manager
JPMORGAN CHASE & CO
Reporting Manager
JPMORGAN CHASE & CO.
Security
Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares
Symbol
RADX
Shares outstanding
2,263,538,657 shares
Disclosed Ownership
230,880,943 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
11 Feb 2025, 12:16:38 UTC
Date of event
31 Dec 2024
Next filing
16 Jul 2025
SEC
View on sec.gov

Quoteable Key Fact

"JPMORGAN CHASE & CO disclosed 10% ownership in Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares (RADX) on 31 Dec 2024."

Quick Takeaways

  • JPMORGAN CHASE & CO filed SCHEDULE 13G for Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares (RADX).
  • Disclosed ownership: 10%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 11 Feb 2025, 12:16.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JPMORGAN CHASE & CO. 10% 230,880,943 230,880,943 0 Rachel Tsvaygoft Vice President